Your SlideShare is downloading. ×
0
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
04 Differential Diagnosis Of Acute Renal Failure
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

04 Differential Diagnosis Of Acute Renal Failure

2,077

Published on

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,077
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
40
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Breakthrough Therapy for Sleep Difficulties Introduction Getting a restful night of sleep should not be a difficult task. Unfortunately, the inability to sleep is a regular source of frustration and anxiety for as many as half of adults. Today, physicians have many more treatment options than ever before for patients with sleep problems. SONATA * (zaleplon) is the first of a new generation of sleep medications. SONATA is unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties. SONATA has been proven effective as a sleep inducer. In clinical trials, SONATA reduced the time to sleep onset without impairing next-day functioning. SONATA gives patients options. Patients can attempt to fall asleep naturally before they decide to use a sleep medication. SONATA can be taken before bedtime or later, if patients experience trouble falling asleep. Because of this flexibility, SONATA may be taken only on those nights when the patient actually experiences the symptoms of insomnia and at anytime during the night (provided one remains in bed 4 or more hours before becoming active again). SONATA is also fast acting. With treatment, patients fall asleep quickly, within 30 minutes or less, and can wake up ready to function after a restful sleep. This slide presentation will introduce you to the important new prescription sleep medication called SONATA. It is hoped that you find the following information on the management of insomnia educational and useful in your practice. * trademark
  • Transcript

    • 1. Differential Diagnosis of Acute Renal Failure 臺灣大學附設醫院外科 4B 加護病房實習報告 報告者 : 李浩遠 (Intern, 學號 : B8601076) 臺北醫學大學醫學系七年級
    • 2. Definition <ul><li>Acute renal failure (ARF) is defined as a precipitous and significant (>50%) decrease in glomerular filtration rate (GFR) over a period of hours to days , with an accompanying accumulation of nitrogenous wastes in the body. </li></ul>
    • 3. Prerenal Disease <ul><li>True volume depletion </li></ul><ul><li>Advanced liver disease </li></ul><ul><li>Congestive heart failure </li></ul><ul><li>Renal arterial disease </li></ul><ul><li>Perinatal or Neonatal hemorrhage </li></ul><ul><li>Perinatal asphyxia and hyaline membrane disease </li></ul><ul><li>Gastroenteritis </li></ul><ul><li>Congenital and acquired heart diseases </li></ul>
    • 4. Prerenal Disease <ul><li>A reduction in renal blood flow - the most common cause of acute renal failure. </li></ul><ul><li>Occur from true volume depletion or from selective renal ischemia (as in bilateral renal artery stenosis). </li></ul><ul><li>Causes of prerenal azotemia: true volume depletion, advanced liver disease, and congestive heart failure. </li></ul>
    • 5. Prerenal Azotemia Caused by True Volume Depletion <ul><li>In severe cases the patient may be in hypovolemic shock . </li></ul><ul><li>Oliguria is present in most individuals </li></ul><ul><li>Normal or increased urine output indicates that an osmotic agent or other diuretic agent is acting, or that there is tubular dysfunction such as ATN. </li></ul>
    • 6. Prerenal Azotemia Caused by Advanced Liver Disease <ul><li>Liver disease: </li></ul><ul><li>sodium retention, initially manifested as ascites </li></ul><ul><li>a progressive decline in GFR. </li></ul><ul><li>Both humoral and hemodynamic factors play a primary role in the development of these problems. </li></ul>
    • 7. Prerenal Azotemia Caused by Congestive Heart Failure <ul><li>CHF is associated with two major alterations in renal function: </li></ul><ul><li>Sodium retention early in the course of the disease and a decline in GFR as cardiac function worsens. </li></ul><ul><li>Neurohumeroral factors and certain therapies may contribute to these problems. </li></ul>
    • 8. Prerenal Azotemia Caused by Renal arterial disease <ul><li>Renal arterial disease - Renal arterial stenosis (atherosclerotic, fibromuscular dysplasia), embolic disease (septic, cholesterol) </li></ul>
    • 9. Prerenal ARF of Newborns and Infants <ul><li>The most common cause of ARF is prerenal etiologies. </li></ul><ul><li>Prerenal ARF: </li></ul><ul><li>Perinatal hemorrhage - Twin-twin transfusion, complications of amniocentesis, abruptio placenta, birth trauma </li></ul><ul><li>Neonatal hemorrhage - Severe intraventricular hemorrhage, adrenal hemorrhage </li></ul>
    • 10. Prerenal ARF of Newborns and Infants <ul><li>Perinatal asphyxia and hyaline membrane disease (newborn respiratory distress syndrome) both may result in preferential blood shunting away from kidneys (ie, prerenal) to central circulation. </li></ul>
    • 11. Prerenal ARF of Children <ul><li>The most common cause of ARF is prerenal etiologies. </li></ul><ul><li>Prerenal ARF: </li></ul><ul><li>The most common cause of hypovolemia in children is gastroenteritis. </li></ul><ul><li>Congenital and acquired heart diseases are also important causes of decreased renal perfusion in this age group. </li></ul>
    • 12. Symptoms and Signs of Prerenal Failure <ul><li>Patients commonly present with symptoms related to hypovolemia , including thirst, decreased urine output, dizziness, and orthostatic hypotension . </li></ul><ul><li>Look for a history of excessive fluid loss via hemorrhage, GI losses, sweating, or renal sources. </li></ul>
    • 13. Symptoms and Signs of Prerenal Failure <ul><li>Patients with advanced cardiac failure leading to depressed renal perfusion may present with orthopnea and paroxysmal nocturnal dyspnea . </li></ul>
    • 14. Intrinsic Renal Failure <ul><li>Tubular diseases </li></ul><ul><li>Interstitial diseases </li></ul><ul><li>Glomerular diseases </li></ul><ul><li>Vascula diseases </li></ul><ul><li>Nephrotoxins </li></ul><ul><li>Allergic interstitial nephritis </li></ul>
    • 15. Intrinsic Renal Failure <ul><li>Glomerular diseases : Nephritic syndrome of hematuria, edema, and HTN is synonymous with a glomerular etiology of ARF. </li></ul>
    • 16. Intrinsic Renal Failure <ul><li>Tubular diseases : ATN should be suspected in any patient presenting after a period of hypotension secondary to cardiac arrest, hemorrhage, sepsis, drug overdose, or surgery . </li></ul>
    • 17. Intrinsic Renal Failure <ul><li>Interstitial diseases - Acute interstitial nephritis, drug reactions, autoimmune diseases (eg, systemic lupus erythematosus [SLE]), infiltrative disease (sarcoidosis, lymphoma), infectious agents (Legionnaire disease, hantavirus) </li></ul><ul><li>Vascular diseases - Hypertensive crisis, polyarteritis nodosa, vasculitis </li></ul>
    • 18. Intrinsic Renal Failure <ul><li>A careful search for exposure to nephrotoxins should include a detailed list of all current medications and any recent radiologic examinations (ie, exposure to radiologic contrast agents). </li></ul>
    • 19. Intrinsic Renal Failure <ul><li>Allergic interstitial nephritis should be suspected with recent drug ingestion, fevers, rash, and arthralgias . </li></ul>
    • 20. Acute Tubular Necrosis <ul><li>Renal insults , including </li></ul><ul><li>renal ischemia </li></ul><ul><li>exposure to exogenous or endogenous nephrotoxins . </li></ul><ul><li>The net effect is a rapid decline in renal function that may require a period of dialysis before spontaneous resolution occurs. </li></ul>
    • 21. Acute Tubular Necrosis <ul><li>There are two major histiologic changes that take place in ATN: </li></ul><ul><li>(1) tubular necrosis with sloughing of the epithelial cells </li></ul><ul><li>(2) occlusion of the tubular lumina by casts and by cellular debris </li></ul>
    • 22. Acute Tubular Necrosis <ul><li>In addition of the tubular obstruction , two other factors appear to contribute to the development of renal failure in ATN: </li></ul><ul><li>across the damaged tubular epithelia backleak of filtrate and </li></ul><ul><li>a primary reduction in glomerular filtration . </li></ul>
    • 23. Acute Tubular Necrosis <ul><li>The decrease in glomerular filtration results both from arteriolar vasoconstriction and from mesangial contraction . </li></ul><ul><li>The decline in renal function begins abruptly following a hypotensive episode, rhabdomyolysis, or the administration of a radiocontrast media . </li></ul><ul><li>When aminoglycosides are the cause, the onset is more insidious , with the first rise in creatinine being at seven or more days. </li></ul>
    • 24. Major Causes of Acute Tubular Necrosis <ul><li>Renal Ischemia : </li></ul><ul><li>* Severe prerenal disease from any cause. </li></ul><ul><li>Exposure to Nephrotoxins : </li></ul><ul><li>* Amphotericin B </li></ul><ul><li>* Aminoglycosides * Heme Pigments * NSAID's (hemoglobinuria/myoglobinura) </li></ul>
    • 25. Intrinsic ARF of Children <ul><li>Hemolytic uremic syndrome (HUS) often is cited as the most common cause of ARF in children. The most common form of the disease is associated with a diarrheal prodrome caused by Escherichia coli 0157:H7. </li></ul><ul><li>These children usually present with microangiopathic anemia, thrombocytopenia, colitis, mental status changes, and renal failure. </li></ul>
    • 26. Post-renal ARF <ul><li>Diseases causing urinary obstruction from the level of the renal tubules to the urethra </li></ul><ul><ul><li>Tubular obstruction from crystals (eg, uric acid, calcium oxalate, acyclovir, sulfonamide, methotrexate, myeloma light chains) </li></ul></ul><ul><ul><li>Ureteral obstruction - Retroperitoneal tumor, retroperitoneal fibrosis (methysergide, propranolol, hydralazine), urolithiasis, papillary necrosis </li></ul></ul>
    • 27. Post-renal ARF <ul><li>Urethral obstruction - Benign prostatic hypertrophy; prostate, cervical, bladder, colorectal carcinoma; bladder hematoma; bladder stone; obstructed Foley catheter; neurogenic bladder; stricture </li></ul>
    • 28. FeNa <ul><li>Calculation of fractional excretion of sodium (FeNa) </li></ul><ul><li>FeNa = (urine Na/plasma Na)/(urine creatinine/plasma creatinine) </li></ul><ul><li>FeNa <1 % = prerenal ARF </li></ul><ul><li>FeNa >1% = ATN </li></ul>
    • 29. FeNa <ul><li>Exceptions (intrinsic renal failure with FeNa <1%) </li></ul><ul><li>Urinary tract obstruction </li></ul><ul><li>Acute glomerulonephritis </li></ul><ul><li>Hepatorenal syndrome </li></ul><ul><li>Radiologic contrast induced ATN </li></ul><ul><li>Myoglobinuric and hemoglobinuric ARF </li></ul><ul><li>Renal allograft rejection </li></ul><ul><li>Drug-related alterations in renal hemodynamics (eg, captopril, NSAIDs) </li></ul>
    • 30. Urine output (>400 mL/d) Acute interstitial nephritis, acute glomerulonephritis, partial obstructive nephropathy, nephrotoxic and ischemic ATN, radiocontrast-induced ARF, and rhabdomyolysis <ul><li>Non-oliguria </li></ul>(100-400 mL/d) Prerenal failure, hepatorenal syndrome <ul><li>Oliguria </li></ul>Urinary tract obstruction, renal artery obstruction, rapidly progressive glomerulonephritis, bilateral diffuse renal cortical necrosis <ul><li>Anuria (<100 mL/d) </li></ul>
    • 31. Urinalysis Acute interstitial nephritis, pyelonephritis WBC casts Glomerulonephritis, malignant HTN RBC casts ATN, glomerulonephritis, interstitial nephritis Granular casts
    • 32. Urinalysis prerenal and postrenal failure, HUS/thrombotic thrombocytopenic purpura (TTP), preglomerular vasculitis, or atheroembolism Normal Acyclovir, sulfonamides, methotrexate, ethylene glycol toxicity, radiocontrast agents Crystall-uria Acute allergic interstitial nephritis, atheroembolism Eosino-philuria
    • 33. Complete blood count multiple myeloma Anemia and rouleaux formation SLE or TTP Leukopenia and thrombocytopenia common in ARF Leukocytosis
    • 34. Complete blood count liver disease or hepatorenal syndrome. Coagulation disturbances allergic interstitial nephritis, polyarteritis nodosa, or atheroemboli Eosinophilia TTP or atheroemboli Microangiopathic anemia
    • 35. Blood chemistry common complication of ARF Hypocalcemia (moderate) Hyperkalemia rapidly progressive liver failure and hepatorenal syndrome Elevations in liver transaminases rhabdomyolysis and myocardial infarction Creatine phosphokinase (CPK) elevations
    • 36. Urine indices <20 >40 Urine/plasma creatinine ratio <10-15 >20 Plasma BUN/creatinine ratio >40 <15-20 Urine sodium (mEq/L) <500 >500 Urine osmolality (mOsm/kg H 2 O) <1.012 >1.018 Urine specific gravity ATN prerenal ARF
    • 37. Laboratory Findings in the Differential Diagnosis of Acute Renal Failure:
    • 38. Laboratory Findings in the Differential Diagnosis of Acute Renal Failure:
    • 39. References Akposso K, Hertig A, Couprie R, et al: Acute renal failure in patients over 80 years old: 25-years' experience [In Process Citation]. Intensive Care Med 2000 Apr; 26(4): 400-6 3 Druml W: Prognosis of Acute Renal Failure. Nephron 1996; 53: 8-15 4 Klahr S, Miller SB: Acute oliguria. N Engl J Med 1998 Mar 5; 338(10): 671-5 2 Liano F, Pascual J: Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996 Sep; 50(3): 811-8 1
    • 40. References Ragaller MJ, Theilen H, Koch T: Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 2001 Feb; 12 Suppl 17: S33-9 6 Moghal NE, Brocklebank JT, Meadow SR: A review of acute renal failure in children: incidence, etiology and outcome. Clin Nephrol 1998 Feb; 49(2): 91-5 5
    • 41. References Renal Failure, Acute September 17, 2002 eMedicine.com, Inc. 8 San A, Selcuk Y, Tonbul Z, Soypacaci Z: Etiology and prognosis in 438 patients with acute renal failure. Ren Fail 1996 Jul; 18(4): 593-9 7

    ×